Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of UK-390,957 for premature ejaculation
2004-004150-51Phase 2Completed
- Sponsor
- Pfizer
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of UK-390957 in premature ejaculation (PE) (2 arms), sponsored by Pfizer. Primary endpoints: Week 8 mean intravaginal ejaculatory latency time and Adverse events. Started Feb 2005; status: completed.
02
Drugs
UK-390957
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on 2004-004150-51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004150-51.